当前位置: 首页 > 期刊 > 《医学信息》 > 2025年第12期
编号:2406186
平喘固本汤合补肺汤联合头孢他啶治疗AECOPD肺肾气虚证的临床疗效及不良反应
http://www.100md.com 2025年7月9日 医学信息 2025年第12期
     关键词:慢性阻塞性肺疾病急性加重期;肺肾气虚证;平喘固本汤;补肺汤;头孢他啶;不良反应 中图分类号:R259 文献标识码:A DOI:10.3969/j.issn.1006-1959.2025.12.023

    文章编号:1006-1959(2025)12-0112-04

    linical Efficacyand Adverse Reactions of Pingchuan Guben Decoction and Bufei Decoction Combined with Ceftazidine in the Treatment of AECOPD with Lung and Kidney Qi Deficiency Syndrome

    XIAO Huiqin

    (DepartmentofItealedicine,DongxiangDistrictHospitalofaditionalhinseMedicine,FuzhouO,Jiagiina)

    ceftazidineintetreametofuteexacebatioofocriepulmoarydsseEo)ingdidyidfccsdo Methodsotalof58patientsithECOdmitedtogiangDistrictHsptalofTadioalCineseedicieofFuzoufroOctob22 toDecember23eeleednddvidditocontrolgou(9patints)ndeatiogoup9patints)bydoumbertableode controlgoupastreatedwitfadeilthseatiogoreatedithngcanGubendotioomindithfeecoctio combiedidia disappearancetimeandadversereactionswerecomparedbetweenthetwogroups.ResultsTheinterventiongroupshowedsignificantlyhigher treatment efficacy than the control group( P- lt;0.05).Both groups showed significant decreased in TCM symptom scores(chest distension,dyspnea, coughwithexptoatio)ostreantompedtoselinhileteetioopsdsigfcantlywerCsptoostan those in the control group Plt;0.05) :( Plt; 0.05).The observationgroupalsoshowed shorterdurations in both hospital stayand symptom disappearance time than those in the control group ( Pe lt;0.05).No statistically significant difference was observed inthe incidenceofadversereactions between the two groups( Pgt;0.05 ).ConclusionPinghuanGubendecoctioncombined withBufeidecoctioncombinedwithceftazidineisefectiveinthetreatmentof AECOPDwithdedcealcetore patients ......

您现在查看是摘要页,全文长 10682 字符